Back to Search Results
Pierre Giglio
Schedule an appointment (614) 293-4448
Insurances We Accept
I am a neuro-oncologist specializing in more than 35 forms of nervous system cancers, with a research focus on glioblastoma. I serve as an associate professor in the neurology department at the OSUCCC – James and working alongside the talented cancer researchers and clinicians in the division of neuro-oncology is a truly rewarding experience. At The James, we are advocates for our patients and continuously seek new ways to provide the most effective treatments possible.

Treating nervous system cancers requires a management approach that includes not just one physician but a team of specialists, including neurosurgeons, radiation oncologists, pathologists, neuroimaging specialists and more. Our team works with innovative technologies to perform genetic and molecular analysis of brain tumors. The combination of our expertise and technological capabilities at The James means patients receive individualized treatment plans for their specific needs.

Research is also a major component of my career. I participate in the translational therapeutics research program at the OSUCCC – James, where I design clinical trials and targeted therapies. My research focus is on glioblastoma and metastatic disease in the central nervous system.

I am also interested in developing alternative cancer therapies. Recently, I investigated a therapy for brain tumors utilizing components of the citrus, ginger and mushroom families that was published in the journal Tumor Biology. My work has also been published in several other top medical journals, including Anticancer Research and Neuro-Oncology.

Medical Degree

  • M.D.
    University of Malta
    6/30/1993

Residency

  • Neurology
    State University of New York at Buffalo
    6/22/1998 - 6/21/2001

Specialties and conditions I treat

  • Neurooncology
  • Neurology
  • Pituitary Cancers
  • Myelitis, Transverse
  • Peripheral Nerve Tumor
  • Lambert-Eaton Myasthenic Syndrome
  • Paraneoplastic Polyneuropathy
  • Neurilemmoma
  • Pinealoma
  • Optic Nerve Glioma
  • Neurocytoma
  • Neurofibrosarcoma
  • Meningioma
  • Opsoclonus-Myoclonus Syndrome
  • Neurofibroma, Plexiform
  • Brain Stem Tumor
  • Cerebellar Cancers
  • Meningeal Carcinomatosis
  • Limbic Encephalitis
  • Nerve Sheath Tumors
  • Neurofibroma
  • Spinal Cord Tumors
  • Cerebral Ventricle Tumor
  • Choroid Plexus Tumor
  • Papilloma, Choroid Plexus
  • Infratentorial Cancers
  • Hypothalamic Cancers
  • Pallister-Hall Syndrome
  • Supratentorial Cancers
  • Arachnoid Cysts
  • Central Nervous System Cysts
  • Colloid Cysts
  • Meningeal Cancers
  • Epidural Tumor
  • Benign or Malignant Cranial Nerve Tumors
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis
  • Paraneoplastic Cerebellar Degeneration
  • Glioblastoma
  • Metastasis Cancers
  • Brain Cancers

Locations where I practice

Please note: Not all physicians schedule patients at each listed location. Please call the “Schedule an appointment” number shown above for scheduling assistance.

More about my work

My background

Fellowships

  • Clinical Neurophysiology / Neuromuscular Medicine
    University of Chicago Hospitals
    7/1/2003 - 6/30/2004
  • Neuro-Oncology
    MD Anderson Cancer Center
    7/1/2001 - 6/30/2003

Board Certifications

American Board of Psychiatry & Neurology (Subspecialty: Clinical Neurophysiology)
9/30/2012

American Board of Psychiatry & Neurology (Subspecialty: Neurology)
9/30/2002

My Department

Neurology

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 03/28/17, Dr. Giglio has reported no financial relationships with medical device, research and/or drug companies.